National drug plan process doesn’t add up

Nigel Rawson | Hamilton Spectator | 17 FEB 2022

Post navigation

Previous Severely reducing drug prices by federal regulation will harm not help patients

Next New patented medicines regulations reflect the general evidence deficiency in Canadian pharmaceutical policy

MORE
Articles
Opinions
Submissions
E-news

Canadian Health Policy

The journal of the Canadian Health Policy Institute

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.